Chart Outlooks for HTDS, GCKO, and ZHNE

Stocks are up pretty firmly to kick-off the shortened trading week, though only one of the three compelling stocks we found in the batch even looks close to bullish (and that one's only of the 'no longer bearish' variety). GeckoSystems Intl. Corp. (PINK:GCKO), Hard to Treat Diseases (PINK:HTDS), and Zhone Technologies, Inc. (NASDAQ:ZHNE) are under the trading microscope today; here's what we're seeing.

It's kind of hard to say that Zhone Technologies, Inc. (NASDAQ:ZHNE) isn't in some big-time trouble, when you zoom out to the weekly chart. In fact, I don't see anything that could salvage the stock at this point. 

For starters, the last of the rising support lines for Zhone Technologies shares (both marked in blue) was breached last week. The lower low this week in the face of a bullish market speaks volumes. In fact, the lower low ZHNE shares made today has also pulled the chart under the second of its key Fibonacci retracement lines. Oh, and the bearish MACD cross came weeks ago.

As for a target for Zhone Technologies, Inc., there may be support at $0.26, where shares dipped ad bounced July. That's flimsy support though. I wouldn't be surprised to see ZHNE fall all the way back to last year's lows. Whatever the ultimate outcome, there's more downside in store.

The clues here are the volume, and the price trend, for GeckoSystems shares. Following the surge to a close of $0.0459 on the 4th and the peak of $0.058 on the next trading day (the 7th), it's been nothing but downhill for GCKO. However, the last two days the stock actually moved lower (the 15th and 16th), volume was extremely light. Since the 16th, GeckoSystems Intl. has just moved sideways.

A hint that GCKO is moving higher? Not quite yet - we'll need a slight uptick to start thinking that way. It is a clear sign that GeckoSystems Intl. Corp. isn't moving lower anymore though. I'd say there's much less risk in owning the stock at this point. The key from here is following the volume.

Hard to Treat Diseases (PINK:HTDS) may be up a hair today, but I suspect the damage is already done. As such, this chart may have a lot more selling to go before the bulk of the supply is abated.

I've talked about this before for Hard to Treat Diseases.... support at $0.007, and resistance around $0.021, which together made a horizontal trading range. When HTDS broke under that support in early December, I rightfully suspected the worst - the stock hit a low of $0.004 a few days later, on the 10th. As of today though....

The bounce effort that Hard to Treat Diseases started on the 11th offered some hope, but look where it stopped - at $0.008, which was essentially where the floor had previously been. Given that floors often become ceilings, I'm giving this instance of the phenomenon its due, particularly now that the HTDS has been sent lower again. The stock remains en route to my original (and stunning) target of $0.001, where support was made in mid-year.

Follow any changes in our opinion of HTDS. GCKO, and HTDS... Sign-up for our FREE Small Cap Network Newsletter TODAY! Quickly identify trends in current market activity and receive timely trading ideas from top SCN Community traders and investors!